Benny Bang is the man behind Brintellix
Last week, Benny Bang-Andersen was named honorary Professor at the University of Copenhagen. The Lundbeck scientist spoke to MedWatch about the satisfaction of having discovered a drug poised to generate billions for his employer.
BY STEFAN SINGH KAILAY
Friday last week, Benny Bang-Andersen returned to the place that laid the foundation for his career and the discovery of a drug that could potentially generate revenue of more than a billion dollars.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Lundbeck: Reimbursement as expected
For abonnenter
Analyst: Lundbeck has gained advantage
For abonnenter
R&D chief: Brintellix data are highly significant
For abonnenter
